Account
Webinar
27.04.2023
Implications of the EU HTA Process for Manufacture...

Our experts discuss the latest news and updates on the EU HTA process, including implications for ma...

Read more
Case Studies
26.04.2023
Development of an EU go-to-market access plan

Our client is developing best-in-class antibodies to neutralise coronaviruses. Our client wanted to...

Read more
Case Studies
26.04.2023
Gaining payer insights

Our client required focused payer value messages for their PUMA product as payers were not recognisi...

Read more
Case Studies
26.04.2023
Gaining payer insights

Our client required focused payer value messages for their PUMA product as payers were not recognizi...

Read more
Case Studies
26.04.2023
Developing a pharmacy submission pack

Our client wanted to broaden access and funding for their reproduction biosimilar in the UK. However...

Read more
Case Studies
26.04.2023
Determining the UK pricing and access strategy

Our client is developing an innovative medical device for use in Type 2 diabetes (T2D). The client w...

Read more
Case Studies
26.04.2023
Gaining payer insights into pricing, reimbursement

Our client has developed an innovative digital health platform to prevent falls. Due to the platform...

Read more
Case Studies
26.04.2023
Communicating the value of a digital nutritional

Our client felt that their current value proposition was insufficient in communicating the benefits ...

Read more
Case Studies
26.04.2023
Managing EMA parallel scientific advice process

Our client wanted to undertake joint payer scientific advice between the EMA and 5 national HTA bodi...

Read more
Case Studies
26.04.2023
Development and refinement of payer value messages

Conduct a rapid pricing and market access (P&MA) assessment across the US and EU5 in order to determ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.